MECOM and head and neck squamous cell carcinoma: The same study did not find any prognostic significance of EVI1 expression in HNSCC [31]; accordingly, we found only marginal effects of EVI1 on cellular sensitivity to chemotherapeutic drugs used in HNSCC therapy, if any (data not shown).